Vertex Pharmaceuticals Incorporated held its annual meeting of shareholders on May 14, 2025. At the meeting, shareholders elected members to the Board of Directors. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2025, was ratified. A shareholder proposal regarding excessive golden parachutes was not approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vertex Pharmaceuticals Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000875320-25-000194), on May 14, 2025, and is solely responsible for the information contained therein.